NCT05415137Phase 3Completed

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Study sponsor: aTyr Pharma, Inc. · ATYR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-06-25Actual
Enrollment · participants268Actual
Source updated2026-06-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Jul 2025. After: 25 Jun 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview